146 related articles for article (PubMed ID: 31147948)
21. The labyrinth unfolds: architectural rearrangements of the endolysosomal system in antigen-presenting cells.
Perrin P; Jongsma ML; Neefjes J; Berlin I
Curr Opin Immunol; 2019 Jun; 58():1-8. PubMed ID: 30738283
[TBL] [Abstract][Full Text] [Related]
22. Kinetics and intracellular pathways required for major histocompatibility complex II-peptide loading and surface expression of a fluorescent hapten-protein conjugate in murine macrophage.
Weaver DJ; Voss EW
Immunology; 1999 Apr; 96(4):557-68. PubMed ID: 10233742
[TBL] [Abstract][Full Text] [Related]
23. Carbon monoxide decreases endosome-lysosome fusion and inhibits soluble antigen presentation by dendritic cells to T cells.
Tardif V; Riquelme SA; Remy S; Carreño LJ; Cortés CM; Simon T; Hill M; Louvet C; Riedel CA; Blancou P; Bach JM; Chauveau C; Bueno SM; Anegon I; Kalergis AM
Eur J Immunol; 2013 Nov; 43(11):2832-44. PubMed ID: 23852701
[TBL] [Abstract][Full Text] [Related]
24. 3-D Structure of multilaminar lysosomes in antigen presenting cells reveals trapping of MHC II on the internal membranes.
Murk JL; Lebbink MN; Humbel BM; Geerts WJ; Griffith JM; Langenberg DM; Verreck FA; Verkleij AJ; Koster AJ; Geuze HJ; Kleijmeer MJ
Traffic; 2004 Dec; 5(12):936-45. PubMed ID: 15522096
[TBL] [Abstract][Full Text] [Related]
25. Early endosomal maturation of MHC class II molecules independently of cysteine proteases and H-2DM.
Villadangos JA; Driessen C; Shi GP; Chapman HA; Ploegh HL
EMBO J; 2000 Mar; 19(5):882-91. PubMed ID: 10698930
[TBL] [Abstract][Full Text] [Related]
26. Redirecting soluble antigen for MHC class I cross-presentation during phagocytosis.
Hari A; Ganguly A; Mu L; Davis SP; Stenner MD; Lam R; Munro F; Namet I; Alghamdi E; Fürstenhaupt T; Dong W; Detampel P; Shen LJ; Amrein MW; Yates RM; Shi Y
Eur J Immunol; 2015 Feb; 45(2):383-95. PubMed ID: 25378230
[TBL] [Abstract][Full Text] [Related]
27. Evidence for invariant chain 85-101 (CLIP) binding in the antigen binding site of MHC class II molecules.
Bangia N; Watts TH
Int Immunol; 1995 Oct; 7(10):1585-91. PubMed ID: 8562503
[TBL] [Abstract][Full Text] [Related]
28. Presentation of acquired peptide-MHC class II ligands by CD4+ regulatory T cells or helper cells differentially regulates antigen-specific CD4+ T cell response.
Zhou G; Ding ZC; Fu J; Levitsky HI
J Immunol; 2011 Feb; 186(4):2148-55. PubMed ID: 21242518
[TBL] [Abstract][Full Text] [Related]
29. Presentation of endogenously synthesized MHC class II-restricted epitopes by MHC class II cancer vaccines is independent of transporter associated with Ag processing and the proteasome.
Dissanayake SK; Tuera N; Ostrand-Rosenberg S
J Immunol; 2005 Feb; 174(4):1811-9. PubMed ID: 15699107
[TBL] [Abstract][Full Text] [Related]
30. Antigen loading of MHC class I molecules in the endocytic tract.
Kleijmeer MJ; Escola JM; UytdeHaag FG; Jakobson E; Griffith JM; Osterhaus AD; Stoorvogel W; Melief CJ; Rabouille C; Geuze HJ
Traffic; 2001 Feb; 2(2):124-37. PubMed ID: 11247303
[TBL] [Abstract][Full Text] [Related]
31. Present Yourself! By MHC Class I and MHC Class II Molecules.
Rock KL; Reits E; Neefjes J
Trends Immunol; 2016 Nov; 37(11):724-737. PubMed ID: 27614798
[TBL] [Abstract][Full Text] [Related]
32. Trafficking of MHC class II molecules in the late secretory pathway.
Hiltbold EM; Roche PA
Curr Opin Immunol; 2002 Feb; 14(1):30-5. PubMed ID: 11790530
[TBL] [Abstract][Full Text] [Related]
33. Invariant chain as a vehicle to load antigenic peptides on human MHC class I for cytotoxic T-cell activation.
Wälchli S; Kumari S; Fallang LE; Sand KM; Yang W; Landsverk OJ; Bakke O; Olweus J; Gregers TF
Eur J Immunol; 2014 Mar; 44(3):774-84. PubMed ID: 24293164
[TBL] [Abstract][Full Text] [Related]
34. Fc epsilon receptor I on dendritic cells delivers IgE-bound multivalent antigens into a cathepsin S-dependent pathway of MHC class II presentation.
Maurer D; Fiebiger E; Reininger B; Ebner C; Petzelbauer P; Shi GP; Chapman HA; Stingl G
J Immunol; 1998 Sep; 161(6):2731-9. PubMed ID: 9743330
[TBL] [Abstract][Full Text] [Related]
35. Membrane specializations and endosome maturation in dendritic cells and B cells.
Boes M; Cuvillier A; Ploegh H
Trends Cell Biol; 2004 Apr; 14(4):175-83. PubMed ID: 15066635
[TBL] [Abstract][Full Text] [Related]
36. The bio-logical role of invariant chain (Ii) in MHC class II antigen presentation.
Nordeng TW; Bakke O
Immunol Lett; 1994 Dec; 43(1-2):47-55. PubMed ID: 7737689
[TBL] [Abstract][Full Text] [Related]
37. Presentation of antigens by MHC class II molecules: getting the most out of them.
Villadangos JA
Mol Immunol; 2001 Sep; 38(5):329-46. PubMed ID: 11684289
[TBL] [Abstract][Full Text] [Related]
38. Endosomal proteolysis and MHC class II function.
Chapman HA
Curr Opin Immunol; 1998 Feb; 10(1):93-102. PubMed ID: 9523118
[TBL] [Abstract][Full Text] [Related]
39. Variations in MHC Class II Antigen Processing and Presentation in Health and Disease.
Unanue ER; Turk V; Neefjes J
Annu Rev Immunol; 2016 May; 34():265-97. PubMed ID: 26907214
[TBL] [Abstract][Full Text] [Related]
40. Quality control of MHC class II associated peptides by HLA-DM/H2-M.
Vogt AB; Arndt SO; Hämmerling GJ; Kropshofer H
Semin Immunol; 1999 Dec; 11(6):391-403. PubMed ID: 10625593
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
